UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Cancer, 2014-02, Vol.120 (3), p.344-351

2014

Link zum Volltext

Verfügbarkeit prüfen

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2329-2339

2008

Link zum Volltext

Verfügbarkeit prüfen

Foreword

Gynecologic oncology, 2022-08, Vol.166, p.S1

2022

Link zum Volltext

Verfügbarkeit prüfen

Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity

Obstetrical & gynecological survey, 2012-02, Vol.67 (2), p.96-97

2012

Link zum Volltext

Verfügbarkeit prüfen

Clues to the origins of ovarian cancer: Family history assessment, genetic screening are key to prevention

Contemporary ob/gyn, 2022-04, Vol.67 (4), p.18

2022

Link zum Volltext

Verfügbarkeit prüfen

Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer

Annals of surgical oncology, 2021-05, Vol.28 (12), p.7795-7806

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of Risk-Reducing Salpingo-Oophorectomy on Sex-Steroid Hormone Serum Levels among Post-Menopausal Women: An NRG Oncology/GOG Study

American journal of obstetrics and gynecology, 2022-02, Vol.227 (1), p.61.e1-61.e18

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract NT-097: QUANTITATIVE HIGH-THROUGHPUT SCREENING USING AN ORGANOTYPIC MODEL IDENTIFIES TWO KINASE INHIBITORS THAT INHIBIT OVARIAN CANCER METASTASIS

Clinical cancer research, 2019-11, Vol.25 (22_Supplement), p.NT-097-NT-097

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5899: Compartment-resolved proteomics reveal NNMT as a master metabolic regulator of cancer associated fibroblasts

Cancer research (Chicago, Ill.), 2017, Vol.77 (13_Supplement), p.5899-5899

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract TMEM-118: ROLES OF T-LAK CELL-ORIGINATED KINASE (TOPK) AND THE MICROENVIRONMENT IN DRIVING OVARIAN CANCER PROGRESSION

Clinical cancer research, 2017-06, Vol.23 (11_Supplement), p.TMEM-118-TMEM-118

2017

Link zum Volltext

Verfügbarkeit prüfen

Metabolic reprogramming of the stromal epigenome in ovarian cancer metastasis

The FASEB journal, 2019-04, Vol.33 (S1), p.lb240-lb240

2019

Link zum Volltext

Verfügbarkeit prüfen

β3 -Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer

The American journal of pathology, 2009-11, Vol.175 (5), p.2184-2196

2009

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1870: Omental adipocytes promote overexpression of CD36 in ovarian cancer cells and enhance tumorigenicity

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1870-1870

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Bevacizumab in Recurrent Sex Cord-Stromal Ovarian Tumors: Results of a Phase II Trial of the Gynecologic Oncology Group

Cancer, 2013-10, Vol.120 (3), p.344-351

2013

Link zum Volltext

Verfügbarkeit prüfen

A Phase Ii Trial Of Selumetinib (Azd6244) In Women With Recurrent Low-Grade Serous Carcinoma Of The Ovary Or Peritoneum: A Gynecologic Oncology Group Trial

The lancet oncology, 2013-02, Vol.14 (2), p.134-140

2013

Link zum Volltext

Verfügbarkeit prüfen

Foretinib (GSK1363089), an orally available multi-kinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis

Clinical cancer research, 2011-05, Vol.17 (12), p.4042-4051

2011

Link zum Volltext

Verfügbarkeit prüfen

β 3-Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer

The American journal of pathology, 2009, Vol.175 (5), p.2184-2196

2009

Link zum Volltext

Verfügbarkeit prüfen

Ovarian Carcinoma Cell Cultures Are Resistant to TGF-β1-Mediated Growth Inhibition Despite Expression of Functional Receptors

Gynecologic oncology, 1999-10, Vol.75 (1), p.72-77

1999

Link zum Volltext

Verfügbarkeit prüfen

Primary gynecologic lymphoma when diagnosed by a gynecologist: A case series

Gynecologic oncology reports, 2024, Vol.53, p.101409-101409

2024

Link zum Volltext

Verfügbarkeit prüfen

Superior vena cava syndrome associated with uterine serous carcinoma

Gynecologic oncology reports, 2020, Vol.33, p.100593-100593

2020

Link zum Volltext

Verfügbarkeit prüfen

Phyllodes tumor of the vulva: A case report and literature review highlighting a novel manifestation of Cowden syndrome

Gynecologic oncology reports, 2021, Vol.36, p.100752-100752

2021

Link zum Volltext

Verfügbarkeit prüfen

Intent-to-Treat Analysis of Stage Ib and IIa Cervical Cancer in the United States: Radiotherapy or Surgery 1988–1995

Obstetrics and gynecology (New York. 1953), 2001-02, Vol.97 (2), p.248-254

2001

Link zum Volltext

Verfügbarkeit prüfen

Altered expression of transforming growth factor-? ligands and receptors in primary and recurrent ovarian carcinoma

Cancer, 1999-02, Vol.85 (3), p.658-668

1999

Link zum Volltext

Verfügbarkeit prüfen

Second primary rhabdomyosarcoma of the uterine cervix presenting with synchronous ovarian Sertoli-Leydig cell tumor: An illustrative case of DICER1 syndrome

Gynecologic oncology reports, 2018, Vol.25, p.94-97

2018

Link zum Volltext

Verfügbarkeit prüfen

Characteristics associated with first job satisfaction and burnout in early-career gynecologic oncologists (031)

Gynecologic oncology, 2022-08, Vol.166, p.S22-S23

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

KollektionBMJ Publishing

ThemaOvarian Neoplasms - Pathology

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(53)

Publikationsform

Sprache

Englisch
(54)
Japanisch
(5)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Foreword

Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity

Clues to the origins of ovarian cancer: Family history assessment, genetic screening are key to prevention

Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer

Effect of Risk-Reducing Salpingo-Oophorectomy on Sex-Steroid Hormone Serum Levels among Post-Menopausal Women: An NRG Oncology/GOG Study

Abstract NT-097: QUANTITATIVE HIGH-THROUGHPUT SCREENING USING AN ORGANOTYPIC MODEL IDENTIFIES TWO KINASE INHIBITORS THAT INHIBIT OVARIAN CANCER METASTASIS

Abstract 5899: Compartment-resolved proteomics reveal NNMT as a master metabolic regulator of cancer associated fibroblasts

Abstract TMEM-118: ROLES OF T-LAK CELL-ORIGINATED KINASE (TOPK) AND THE MICROENVIRONMENT IN DRIVING OVARIAN CANCER PROGRESSION

Metabolic reprogramming of the stromal epigenome in ovarian cancer metastasis

β3 -Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer

Abstract 1870: Omental adipocytes promote overexpression of CD36 in ovarian cancer cells and enhance tumorigenicity

Efficacy and Safety of Bevacizumab in Recurrent Sex Cord-Stromal Ovarian Tumors: Results of a Phase II Trial of the Gynecologic Oncology Group

A Phase Ii Trial Of Selumetinib (Azd6244) In Women With Recurrent Low-Grade Serous Carcinoma Of The Ovary Or Peritoneum: A Gynecologic Oncology Group Trial

Foretinib (GSK1363089), an orally available multi-kinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis

β 3-Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer

Ovarian Carcinoma Cell Cultures Are Resistant to TGF-β1-Mediated Growth Inhibition Despite Expression of Functional Receptors

Primary gynecologic lymphoma when diagnosed by a gynecologist: A case series

Superior vena cava syndrome associated with uterine serous carcinoma

Phyllodes tumor of the vulva: A case report and literature review highlighting a novel manifestation of Cowden syndrome

Intent-to-Treat Analysis of Stage Ib and IIa Cervical Cancer in the United States: Radiotherapy or Surgery 1988–1995

Altered expression of transforming growth factor-? ligands and receptors in primary and recurrent ovarian carcinoma

Second primary rhabdomyosarcoma of the uterine cervix presenting with synchronous ovarian Sertoli-Leydig cell tumor: An illustrative case of DICER1 syndrome

Characteristics associated with first job satisfaction and burnout in early-career gynecologic oncologists (031)

Aktive Filter

Suchergebnisse filtern